Press release
Glucagon-like Peptide 1 Market Global Trends, Industry Analysis, Size, Share, Growth Factors and Forecast 2033
Glucagon-like Peptide 1 Market Report
Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=10830&type=smp
Escalating Diabetes Prevalence Drives The Global Glucagon-Like Peptide 1 Market
The rising prevalence of diabetes is expected to propel the global glucagon-like peptide 1 market going forward. Diabetes is a condition in which the blood sugar, or blood glucose, is too high. Glucagon-like peptide 1 is a medication used to treat conditions such as type 2 diabetes that may lead to weight loss and improved blood sugar. For instance, in January 2022, according to the National Library of Medicine, a US-based center of biomedical informatics and computational biology, it was estimated that global diabetes prevalence in 20-79-year-olds in 2021 was 10.5% (536.6 million people), and it is expected to increase to 12.2% (783.2 million) in 2045. Therefore, the rising prevalence of diabetes will drive glucagon-like peptide 1.
Novo Nordisk Introduces Wegovy, A Once-Weekly Glucagon-Like Peptide 1 Therapy For Weight Management
Technological innovations are a key trend gaining popularity in the global glucagon-like peptide 1 market. Major companies operating in the glucagon-like peptide 1 market are launching new and innovative technologies to sustain their position in the market. For instance, Novo Nordisk A/S, a Denmark-based pharmaceutical company, launched Wegovy, the first and only once-weekly glucagon-like peptide 1 therapy for weight management. Wegovy successfully completed the STEP Phase 3a clinical trial program and demonstrated a safe and well-tolerated profile across the program. This product is used by people who struggle with obesity to achieve and maintain weight loss.
The glucagon-like peptide 1 market covered in this report is segmented -
1) By Product: Trulicity, Ozempic, Victoza, Rybelsus, Other Types
2) By Route of Administration: Oral, Parenteral, Other Routes
3) By End-Users: Hospitals, Specialty Clinics, Other End Users
Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=10830&type=discount
Major companies operating in the glucagon-like peptide 1 market report are Novo Nordisk AS, Sanofi SA, Eli Lilly and Co, AstraZeneca plc, Pfizer Inc, Boehringer Ingelheim International GmbH, F Hoffmann-La Roche Ltd, Bristol-Myers Squibb Company, Baxter, Hikma Pharmaceuticals plc, Zealand Pharma A/S, Intarcia Therapeutics Inc., GlaxoSmithKline plc, Jiangsu Hansoh Pharmaceutical Group Co Ltd, Shanghai Benemae Pharmaceutical Corporation, Adocia, Biocon, Hanmi Pharmaceutical Co Ltd, Ligand Pharmaceuticals Incorporated, Advinus Therapeutics Ltd, Mitsubishi Tanabe Pharma Corporation, Daiichi Sankyo Company Limited, Sun Pharmaceutical Industries Ltd, Union Chimique Belge, Amylin Pharmaceuticals LLC, Academic Pharmaceuticals Inc, ConjuChem Biotechnologies, MannKind Corporation:, Provention Bio Inc, Regeneron Pharmaceuticals
Contents of the report:
1. Executive Summary
2. Glucagon-like Peptide 1 Market Report Structure
3. Glucagon-like Peptide 1 Market Trends And Strategies
4. Glucagon-like Peptide 1 Market - Macro Economic Scenario
5. Glucagon-like Peptide 1 Market Size And Growth
…..
27. Glucagon-like Peptide 1 Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/glucagon-like-peptide-1-global-market-report
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Glucagon-like Peptide 1 Market Global Trends, Industry Analysis, Size, Share, Growth Factors and Forecast 2033 here
News-ID: 3596031 • Views: …
More Releases from The Business Research Company
Future Perspective: Key Factors Influencing the Intelligent Road System Market U …
The intelligent road system market is rapidly advancing as technology and infrastructure evolve to meet the demands of modern transportation. With the rise of autonomous vehicles and smart city initiatives, this sector is set to experience significant growth in the coming years. Here, we explore the market's size, leading players, key trends, and segmentation to provide a comprehensive overview of the intelligent road system landscape.
Strong Growth Outlook for the Intelligent…
Segment Analysis and Major Growth Areas in the Consumer Telematics Market
The consumer telematics market is on the brink of remarkable expansion, driven by increasing demand for vehicle monitoring and safety solutions. Advances in technology combined with growing smartphone usage and affordable data plans are setting the stage for significant market growth. Let's explore the current market size, key players, emerging trends, and detailed segment insights shaping this industry's future.
Consumer Telematics Market Size and Growth Projections
The consumer telematics market…
Worldwide Trends Overview: The Rapid Evolution of the Vehicle Diagnostics Market
The vehicle diagnostics sector is gearing up for significant expansion, driven by rapid technological advancements and evolving automotive needs. As vehicles become increasingly complex and connected, diagnostic solutions are evolving to offer more precise, efficient, and predictive capabilities. Let's explore the current market size, key players, emerging trends, and segmentation details that shape the future of this dynamic industry.
Projected Market Growth and Size of the Vehicle Diagnostics Market
The…
In-Depth Examination of Segments, Industry Trends, and Key Competitors in the El …
The electric vehicle battery swapping market is on the brink of remarkable expansion in the coming years, driven by innovative technologies and growing environmental awareness. As the demand for zero-emission vehicles intensifies, this market is set to transform how electric vehicle users recharge their batteries, promising faster, more convenient solutions. Below is a detailed look at the market's future size, key players, emerging trends, and important segments shaping its trajectory.
Strong…
More Releases for Peptide
ShiLai Peptide to Invest $32 Million in State-of-the-Art Peptide Laboratory in H …
ShiLai Peptide's CEO, Luo Binhua, said the investment reflects the company's commitment to a "new science model" that integrates research-driven development, controlled production, and specialized customer support.
ShiLai Peptide [https://retatrutidesupplier.com/], a leading provider of high-purity, customizable research peptides, announced plans to invest $32 million to build a state-of-the-art peptide research and production laboratory in Hangzhou. The facility is designed to meet world-class GMP standards, aiming to strengthen ShiLai's global supply of…
Copper Peptide GHK-Cu Market: Empowering Beauty and Health Innovations with Adva …
The global copper peptide GHK-Cu market is poised for transformative growth as innovative cosmetic and pharmaceutical formulations increasingly incorporate these bioactive peptides to promote skin rejuvenation, wound healing, and overall wellness. Driven by technological advancements, growing consumer awareness of anti-aging solutions, and an expanding portfolio of product applications, the market is set to evolve rapidly in the coming years. This industry provides an in-depth analysis of market information, key growth…
Shaping the Cell Penetrating Peptide Market in 2025: Innovative Peptide Drug Dis …
How Big Is the Cell Penetrating Peptide Market Expected to Be, and What Will Its Growth Rate Be?
In recent times, the market size for cell penetrating peptides has expanded swiftly. The market is projected to rise from a value of $1.87 billion in 2024 to $2.16 billion in 2025, growing at a compound annual growth rate (CAGR) of 15.6%. The historic period's growth can be credited to an amplified comprehension…
Cancer Peptide Drugs Market
Global Peptide Cancer Drug Market Size, Dosage, Drug Price, Sales & Clinical Trials Insight 2030 Report Highlights:
• Global Peptide Cancer Drug Market Insight By Region & Indication
• Global Peptide Cancer Drug Market Opportunity: > US$ 18 Billion
• Approved Peptide Cancer Drugs: > 30 Drugs
• Approved Peptide Cancer Drugs Sales Insights, Patent, Dosage and Price Analysis
• Peptide Cancer Drugs Clinical Trials Insight By Company, Country, Indication and Phase
• Insight On Peptide Cancer Drugs In Clinical Trials: >…
Global Adjuvant Peptide Market Size,Share, Research and Forecast,2023-2028| Pept …
The global Adjuvant Peptide market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Adjuvant Peptide market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and opportunities of the global…
Peptide Modifications For PEGylation
PEGylation is the process of covalently attaching polyethylene glycol (PEG) polymer chains to peptides. By increasing their molecular mass and shielding them from proteolytic enzymes, PEGylation improves the pharmacokinetics of peptides and proteins. PEGylation reduces renal clearance and results in more sustained absorption after subcutaneous administration, as well as restricted distribution. PEGylations have been shown to significantly improve water solubility, biocompatibility, immunogenicity, and other physico-chemical properties. It is an established…
